Annamaria Nosari, Marco Montillo, Enrica Morra. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » 2-Aminopurine/analogs & derivatives2-Aminopurine/therapeutic useAlemtuzumabAntibiotic ProphylaxisAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/pharmacologyAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Monoclonal, Murine-DerivedAntibodies, Neoplasm/adverse effectsAntibodies, Neoplasm/pharmacologyAntigens, CD/immunologyAntigens, Neoplasm/immunologyAntineoplastic Agents/adverse effectsAntineoplastic Agents/pharmacologyBone Marrow TransplantationCD52 AntigenClinical Trials as TopicCytomegalovirus Infections/etiologyCytomegalovirus Infections/immunologyCytomegalovirus Infections/prevention & controlDisease SusceptibilityFamciclovirGanciclovir/therapeutic useGlycoproteins/antagonists & inhibitorsGlycoproteins/immunologyGraft vs Host Disease/prevention & controlHumansImmunologic Deficiency Syndromes/chemically inducedImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/pharmacologyIncidenceInfections/etiologyLymphoproliferative Disorders/drug therapyOpportunistic Infections/etiologyOpportunistic Infections/prevention & controlPneumonia, Pneumocystis/etiologyPneumonia, Pneumocystis/immunologyPneumonia, Pneumocystis/prevention & controlRituximabTransplantation ConditioningTrimethoprim, Sulfamethoxazole Drug Combination/therapeutic useViremia/etiologyViremia/immunologyViremia/prevention & controlVirus Activation
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, Monoclonal, Murine-DerivedAntibodies, NeoplasmAntigens, CDAntigens, NeoplasmAntineoplastic AgentsCD52 AntigenCD52 protein, humanGlycoproteinsImmunosuppressive AgentsAlemtuzumab2-AminopurineRituximabTrimethoprim, Sulfamethoxazole Drug CombinationGanciclovirFamciclovir
Year: 2004 PMID: 15590388
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941